A detailed history of Iq Eq Fund Management (Ireland) LTD transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Iq Eq Fund Management (Ireland) LTD holds 13,118 shares of BEAM stock, worth $380,553. This represents 0.03% of its overall portfolio holdings.

Number of Shares
13,118
Previous 9,303 41.01%
Holding current value
$380,553
Previous $217,000 47.93%
% of portfolio
0.03%
Previous 0.03%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

BUY
$22.57 - $33.14 $86,104 - $126,429
3,815 Added 41.01%
13,118 $321,000
Q2 2024

Jul 29, 2024

BUY
$21.22 - $32.66 $197,409 - $303,835
9,303 New
9,303 $217,000

Others Institutions Holding BEAM

About Beam Therapeutics Inc.


  • Ticker BEAM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,354,600
  • Market Cap $2.04B
  • Description
  • Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...
More about BEAM
Track This Portfolio

Track Iq Eq Fund Management (Ireland) LTD Portfolio

Follow Iq Eq Fund Management (Ireland) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Iq Eq Fund Management (Ireland) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Iq Eq Fund Management (Ireland) LTD with notifications on news.